MicroRNA-10b Promotes Apoptosis via JNK Pathway in Clear Cell Renal Cell Carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Clear cell renal cell carcinoma (ccRCC) is a significant health concern.
• The role of microRNAs (miRNAs) in ccRCC pathogenesis is an active area of research.
• Specific miRNA dysregulation, like miR-10b downregulation, may contribute to ccRCC development.

Purpose of the Study:

• To investigate the downregulation of microRNA (miR)-10b in clear cell renal cell carcinoma (ccRCC).
• To elucidate the mechanistic involvement of miR-10b in ccRCC tumorigenesis.
• To determine the impact of miR-10b on cell proliferation and apoptosis in ccRCC.

Main Methods:

• Real-time PCR was used to determine miR-10b expression levels in ccRCC samples.
• miR-10b expression and knockdown were achieved using plasmid transfection in 786-0 cells.
• Cell proliferation, apoptosis, and MAPK/JNK pathway activation were assessed using CCK-8 assay, Annexin V/PI staining, and Western blotting, respectively.

Main Results:

• miR-10b was confirmed to be downregulated in ccRCC tumors.
• Forced expression of miR-10b inhibited cell proliferation and induced apoptosis in 786-0 cells.
• Apoptosis induction by miR-10b was mediated by the activation of the JNK pathway.

Conclusions:

• miR-10b functions as a tumor suppressor in ccRCC.
• miR-10b inhibits ccRCC cell proliferation and promotes apoptosis.
• The pro-apoptotic effect of miR-10b in ccRCC is dependent on JNK pathway activation.